Susceptibility ofHelicobacter pylorito antibiotics in Chinese patients
Author:
Affiliation:
1. Department of Gastroenterology; Peking University Third Hospital; Beijing China
2. Department of Laboratory Medicine; Peking University Third Hospital; Beijing China
Funder
Projects from the National Science Technology Pillar Program in the Twelfth Five-Year Plan Period, China
Publisher
Wiley
Subject
Gastroenterology
Reference23 articles.
1. Management of Helicobacter pylori infection - the Maastricht IV/ Florence consensus report;Malfertheiner;Gut,2012
2. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan;Fujimura;Int J Hematol,2005
3. A new look at anti-Helicobacter pylori therapy;Chuah;World J Gastroenterol,2011
4. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease;Xie;Eur J Gastroenterol Hepatol,2013
5. The Sydney system revisited: the Houston International Gastritis Workshop;Genta;Am J Gastroenterol,1995
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Helicobacter pylori antibiotic resistance in different regions of China: A systematic review and meta-analysis;World Chinese Journal of Digestology;2024-01-28
2. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection;Journal of Ethnopharmacology;2024-01
3. Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs;Helicobacter;2023-10-15
4. Current paradigms in the management of refractory Helicobacter pylori infection;Indian Journal of Gastroenterology;2023-09-22
5. Can vitamin B6 alleviate the adverse reactions of quadruple anti-Helicobacter pylori regimen? : randomized controlled trial;BMC Infectious Diseases;2023-09-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3